Figure S1. HLA-A*0201+ pDCs induce virus-specific T-cell responses from HLA-A*0201+ healthy donors' PBMC with a high efficiency in vitro.

Figure S2. High quantity of virus-specific T cells are produced using the peptide-loaded pDC line.

Figure S3. The virus-specific T cells elicited by the pDC line display an MHC/peptide restricted activity without bystander allogeneic reactivity.

Figure S4. The expanded effector cells are cytotoxic in the setting of immunosuppression.

Figure S5. Response of HuPBL mice to vaccination by the peptide-loaded pDC line.

AJT_3722_sm_SuppMat.doc270KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.